The 2021 clinical practice guideline provides evidence-based recommendations and algorithms for the risk stratification and diagnostic workup of adult patients presenting with chest pain.
This executive summary provides updated, evidence-based clinical practice guidelines for the assessment, risk stratification, and diagnostic workup of adult patients presenting with chest pain.
AIM This executive summary of the clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients. METHODS A comprehensive literature search was conducted from November 11, 2017, to May 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Additional relevant studies, published through April 2021, were also considered. STRUCTURE Chest pain is a frequent cause for emergency department visits in the United States. The "2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain" provides recommendations based on contemporary evidence on the assessment and evaluation of chest pain. These guidelines present an evidence-based approach to risk stratification and the diagnostic workup for the evaluation of chest pain. Cost-value considerations in diagnostic testing have been incorporated and shared decision-making with patients is recommended.
Gulati et al. (2021) conducted a review in Chest pain. Guideline recommendations for evaluation and diagnosis was evaluated. The 2021 clinical practice guideline provides evidence-based recommendations and algorithms for the risk stratification and diagnostic workup of adult patients presenting with chest pain.